Should Tesla be Worried About General Motors?

General Motors is now the #2 U.S. EV seller, reporting 48% year-over-year growth in full-year 2025 EV sales and a 32% YoY increase for the Sierra EV in Q4; the Chevy Equinox EV is the top non‑Tesla EV and Cadillac is the top U.S. luxury EV brand. GM has scaled back some near-term EV investments and repurposed capacity for ICE trucks/SUVs, but CEO Mary Barra reiterates EVs remain the company's long-term strategy. Tesla remains diversified beyond car sales — energy generation/storage revenue grew ~27% last year, Cybercab (robotaxi) production is slated to start in April, and Tesla plans to convert Fremont to produce Optimus humanoid robots — supporting the view that EV market share loss to GM may not materially derail Tesla's longer-term thesis.

Analysis

GM’s recent EV traction creates an underappreciated option value in its capital allocation: the ability to flex lines back to ICE/SUV production materially shortens the marginal payback on EV investments and reduces downside capital risk versus pure-play EV challengers. That optionality should compress the perceived execution premium investors assign to Tesla’s growth, particularly if macro-driven demand softens over the next 12–24 months and OEMs shift mix to protect margins.

Second-order winners are battery-material and module integrators plus legacy dealer/finance networks that can monetize trade-in/used-EV pipelines; expect cyclical demand for LFP/NMC sourcing and certified pre-owned platforms to grow 2–3x as inventory turns normalize. Conversely, software-first value pools (OTA updates, subscription FSD-equivalents, robotaxi fleet ops) remain the primary differentiator — failure to monetize these at scale would leave a durable 300–700bp margin gap in favor of pure-software incumbents.

Tail risks sit on two timelines: days–months for incentive shifts, tax-credit cliff effects and seasonal inventory swings; and 18–36 months for outsized binary outcomes from robotaxi/Optimus commercialization. The market is pricing a mixed outcome that overweights long-term optionality (robotaxis, humanoids) and underweights the path-dependent capital and regulatory hurdles that could push those revenue streams beyond a multi-year horizon.

Contrarian read: Tesla’s valuation is far more sensitive to execution on non-vehicle businesses than investors admit — a modest miss in robotaxi timelines or lower-than-expected energy margins can materially re-rate multiples even if EV deliveries grow. That creates a convex trade opportunity to own scaled incumbents and supply-chain beneficiaries while skewing short exposure to concentrated optionality bets.

Key Decisions for Investors

• Pair trade (12–24 months): Long GM (size 1.0–1.5%) financed by Short TSLA (size 0.5–0.75%). Rationale: capture GM’s near-term margin protection and EV volume optionality versus downside to TSLA if robotaxi/Optimus commercialization slips. Risk: Tesla outperforms on software monetization; reward: GM narrows multiple gap if execution stable.
• Long NVDA (0.5–1.0%, 18–36 months) as a call on accelerated data-center and inference demand from robotaxi and autonomous training workloads. Hedge: small short TSLA call position or buy OTM TSLA puts to protect against downside from non-vehicle commercialization misses. Risk/reward: NVDA upside if autonomy scales; downside if robotaxi timelines slip but NVDA secular AI demand cushions drawdown.
• Buy GM equity + long-dated (12–18 month) protective puts on GM as insurance (cost <1% position). Objective: participate in EV share gains while capping tail execution/recall risk. Reward: asymmetric upside if GM converts ICE capacity to EV profitably; cost is limited insured premium.
• Event hedge (0–6 months): If regulatory or incentive news (tax credit renewals/withdrawals) appears, rotate 0.5% into charging-network and used-vehicle play via ETFs or select small caps — these have rapid beta to retail EV adoption shifts and can outperform on quarter-to-quarter policy moves.